Amgen product sales slip but income stays steady
Net income at biotech giant Amgen stayed flat for the third quarter, despite a slight downtick in revenues to $5.8 billion, the company reported Oct. 25. Product sales saw a slight decline, including Neupogen, Epogen and its blockbuster rheumatoid arthritis drug Enbrel, which fell 6 percent, but net income stayed steady at a little more Read More →
Read More →Flir Systems reports third quarter increase in net earnings
Thermal imaging device maker Flir Systems, which has large operations in Goleta, announced a 15 percent increase in its third quarter revenues, driving net earnings up 8 percent. The company saw increases in revenue across all segments, particularly its instruments, security and detection businesses, as well as a 39 percent increase in its original equipment Read More →
Read More →American Riviera Bank assets pass half-billion dollar mark
American Riviera Bank, headquartered in Santa Barbara, had an unaudited net income of $1,383,000, or 31 cents per share, for the third quarter of 2017, the company announced in its earnings report on Oct. 24. The bank reported $518 million in total assets as of the third quarter of 2017. The growth was driven by Read More →
Read More →Third quarter net income rises at Pacific Premier Bank
Pacific Premier Bancorp, parent company of Pacific Premier Bank, had diluted earnings per share of 50 cents for the third quarter of 2017, the company announced its earnings report on Oct. 23. The company said it had net income of $20.2 million for the third quarter of 2017 that reflected an increase of $6.1 million, Read More →
Read More →Biotech giant Amgen to pay dividend on Dec. 8
Biotech giant Amgen announced Oct. 24 that it would pay a $1.15 dividend for its fourth quarter of fiscal 2017. Stockholders of record for the Thousand Oaks-based company at the end of day on Nov. 17 will receive the dividend on Dec. 8.
Read More →Lockheed Martin sales up but net income drops
Lockheed Martin, an aerospace and defense contractor with operations in San Luis Obispo, Santa Maria and Goleta, reported a 5 percent increase in net sales but a steep drop in net income for the quarter ended Sept. 24. Sales rose to nearly $12.2 billion, primarily from the aeronautics and space systems segments, but net earnings Read More →
Read More →Westlake Village biotech company MannKind restructures debt
MannKind announced Oct. 23 that it had restructured debt due in 2018, exchanging $27.7 million in convertible notes for $23.7 million due in October of 2021 and nearly 1 million shares of its common stock. The new convertible senior subordinated exchange notes have a rate of 5.75 percent, the Westlake Village-based biotech company said in Read More →
Read More →
Sponsored content:
2015-2016 Giving Guide
